Elan Investment In Zonegran Marketing Instead Of Clinical Trails Proves Costly In DoJ Settlement

Elan agrees to pay $203.5 million in criminal and civil fines and to enter a corporate integrity agreement; DoJ's complaint cites sales techniques the company developed to encourage doctors to prescribe off-label.